4//SEC Filing
Cox Aaron 4
Accession 0001209191-23-000873
CIK 0001492426other
Filed
Jan 3, 7:00 PM ET
Accepted
Jan 4, 4:13 PM ET
Size
24.3 KB
Accession
0001209191-23-000873
Insider Transaction Report
Form 4
Cox Aaron
EVP, Chief Financial Officer
Transactions
- Exercise/Conversion
Ordinary Shares
2022-12-30+64,906→ 65,183 total - Tax Payment
Ordinary Shares
2022-12-30$113.80/sh−28,758$3,272,660→ 36,425 total - Exercise/Conversion
Performance Restricted Stock Units (PSU)
2022-12-30−5,806→ 0 total→ Ordinary Shares (5,806 underlying) - Exercise/Conversion
Performance Restricted Stock Units (PSU)
2022-12-30−1,573→ 0 total→ Ordinary Shares (1,573 underlying) - Exercise/Conversion
Performance Restricted Stock Units (PSU)
2022-12-30−17,416→ 0 total→ Ordinary Shares (17,416 underlying) - Exercise/Conversion
Performance Restricted Stock Units (PSU)
2022-12-30−3,868→ 0 total→ Ordinary Shares (3,868 underlying) - Exercise/Conversion
Performance Restricted Stock Units (PSU)
2022-12-30−9,318→ 4,654 total→ Ordinary Shares (9,318 underlying) - Exercise/Conversion
Restricted Stock Units (RSU)
2022-12-30−9,676→ 0 total→ Ordinary Shares (9,676 underlying) - Exercise/Conversion
Restricted Stock Units (RSU)
2022-12-30−7,935→ 15,870 total→ Ordinary Shares (7,935 underlying) - Exercise/Conversion
Restricted Stock Units (RSU)
2022-12-30−9,314→ 9,314 total→ Ordinary Shares (9,314 underlying)
Footnotes (4)
- [F1]Each PSU/RSU represents a contingent right to receive one ordinary share of the Issuer.
- [F2]The final tranche of ordinary shares subject to the PSU/RSU vested on December 30, 2022.
- [F3]The remaining ordinary shares subject to the PSU/RSU vest on January 5, 2024.
- [F4]The remaining ordinary shares subject to the RSU vest ratably on January 5, 2024 and January 5, 2025.
Documents
Issuer
Horizon Therapeutics Public Ltd Co
CIK 0001492426
Entity typeother
Related Parties
1- filerCIK 0001924351
Filing Metadata
- Form type
- 4
- Filed
- Jan 3, 7:00 PM ET
- Accepted
- Jan 4, 4:13 PM ET
- Size
- 24.3 KB